# Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders

> **NCT02266433** · PHASE3 · TERMINATED · sponsor: **NYU Langone Health** · enrollment: 245 (actual)

## Conditions studied

- DeQuervains Tenosynovitis
- Lateral Epicondylitis
- Tennis Elbow
- Trigger Finger
- Tenosynovitis
- Inflammatory Disease

## Interventions

- **DRUG:** Ketorolac
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT02266433
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-08
- **Primary completion:** 2018-07-01
- **Final completion:** 2018-07-01
- **Target enrollment:** 245 (ACTUAL)
- **Why stopped:** due to PI's change to private practice
- **Last updated:** 2020-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02266433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02266433, "Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02266433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*